IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
IMI markets a family of surgical probes including Surgical Gamma Probes for sentinel lymph node biopsy in breast cancer and melanoma surgery, and PET Probes for intraoperative Gamma Probe and Beta Probe tumor detection and surgical margin evaluation.
Waspmote Plug & Sense! is a new line of Libelium encapsulated wireless sensor devices allowing system integrators to implement scalable, modular wireless sensor networks and reduce installation time from days to hours
Waspmote Plug & Sense! is a new line of Libelium encapsulated wireless sensor devices allowing system integrators to implement scalable, modular wireless sensor networks and reduce installation time from days to hours